Go Deep
C.E.Management Integrated Laboratory Co.Ltd
C.E.Management Integrated Laboratory Co.Ltd Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 23,939 | 10.3 | 0.97 | 0.11 | 216.72 |
C.E.Management Integrated Laboratory Co.Ltd Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 1,703,956,000.0 | 2,137,383,000.0 | 2,303,714,000.0 | 1,825,220,000.0 |
| Net Profit | -41,997,000.0 | 190,877,000.0 | 301,881,000.0 | 43,518,000.0 |
| EPS | — | 13.4 | — | — |
C.E.Management Integrated Laboratory Co.Ltd Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 7,695,661,000.0 | 7,346,050,000.0 | 7,326,633,000.0 | 6,998,770,000.0 | — |
| Net Profit | 482,989,000.0 | 362,559,000.0 | 190,059,000.0 | 349,821,000.0 | — |
| EPS | 34.0 | 25.5 | 13.4 | 24.6 | — |
C.E.Management Integrated Laboratory Co.Ltd Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Total Assets | 7,352,211,000.0 | 7,028,699,000.0 | 6,861,115,000.0 | 7,013,275,000.0 |
| Total Liabilities | 2,177,465,000.0 | 2,155,770,000.0 | 2,230,009,000.0 | 2,440,181,000.0 |
| Total Equity | 5,174,746,000.0 | 4,872,929,000.0 | 4,631,106,000.0 | 4,573,094,000.0 |
Owes vs Owns
C.E.Management Integrated Laboratory Co.Ltd owed ¥0.28 for every ¥1 it owned in Jun 2026, down from ¥0.35 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.28× | 0.30× | 0.31× | 0.33× | 0.35× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
C.E.Management Integrated Laboratory Co.Ltd Assets & Liabilities Breakdown (JPY millions)
What it owns — Dec 2025
Cash & short-term investments 30.2%Receivables 16.0%Inventory 4.5%Fixed assets (tangible) 32.4%Intangible assets 1.6%Long-term investments 4.7%Other assets 10.6%
How it's funded — Dec 2025
Short-term debt 2.5%Long-term debt 3.0%Payables 3.7%Other liabilities 20.4%Shareholders' equity 70.4%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 2,223.7 | 2,270.6 | 2,138.3 | 1,746.8 |
| Receivables | 1,177.0 | 1,088.0 | 1,054.1 | 1,173.1 |
| Inventory | 332.7 | 303.8 | 313.1 | 332.5 |
| Fixed assets (tangible) | 2,381.3 | 2,241.0 | 2,102.8 | 2,192.6 |
| Intangible assets | 115.7 | 205.7 | 306.4 | 571.8 |
| Long-term investments | 345.6 | 353.8 | 387.1 | 342.9 |
| Other assets | 776.2 | 565.7 | 559.3 | 653.5 |
| Liabilities & equity | ||||
| Short-term debt | 186.8 | 171.0 | 217.4 | 266.7 |
| Long-term debt | 218.6 | 323.8 | 494.7 | 707.6 |
| Payables | 268.6 | 226.4 | 231.5 | 292.8 |
| Other liabilities | 1,503.4 | 1,434.6 | 1,286.3 | 1,173.1 |
| Shareholders' equity | 5,174.7 | 4,872.9 | 4,631.1 | 4,573.1 |
| Net tangible assets | 5,059.0 | 4,667.2 | 4,324.7 | 4,001.3 |
C.E.Management Integrated Laboratory Co.Ltd Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 490,308,000.0 | 686,403,000.0 | 952,546,000.0 | 329,491,000.0 | — |
| Investing Activities | -219,392,000.0 | -111,493,000.0 | -82,048,000.0 | 545,842,000.0 | — |
| Financing Activities | -317,041,000.0 | -443,835,000.0 | -479,708,000.0 | -340,953,000.0 | — |